These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 1488404)
1. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Lee YH; Lee MH; Shim CK Pharm Res; 1992 Dec; 9(12):1599-606. PubMed ID: 1488404 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits. Choi JS; Lee JH; Burm JP Arch Pharm Res; 2001 Aug; 24(4):333-7. PubMed ID: 11534767 [TBL] [Abstract][Full Text] [Related]
3. Increased availability of propranolol in rats with uranyl nitrate-induced acute renal failure. Katayama H; Fujiwara J; Yasuhara M; Okumura K; Hori R J Pharmacobiodyn; 1984 Aug; 7(8):536-44. PubMed ID: 6512676 [TBL] [Abstract][Full Text] [Related]
4. No effect of diltiazem on the hepatic clearance of indocyanine green in the rats. Joo EH; Lee YB Arch Pharm Res; 1998 Aug; 21(4):411-7. PubMed ID: 9875468 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing. Venkatesh P; Harisudhan T; Choudhury H; Mullangi R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2007; 32(4):189-96. PubMed ID: 18348467 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. Yeung PK; Mosher SJ; Pollak PT Eur J Drug Metab Pharmacokinet; 1991; 16(1):69-74. PubMed ID: 1936064 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure. Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807 [TBL] [Abstract][Full Text] [Related]
8. Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF? Mustafa S; Venkatesh P; Pasha K; Mullangi R; Srinivas NR Xenobiotica; 2006 Dec; 36(12):1239-58. PubMed ID: 17162470 [TBL] [Abstract][Full Text] [Related]
9. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2. Choi YH; Lee YS; Kim TK; Lee BY; Lee MG J Pharm Pharmacol; 2009 Oct; 61(10):1325-32. PubMed ID: 19814864 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of diltiazem in patients with liver cirrhosis. Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure. Kim SH; Shim HJ; Kim WB; Lee MG Antimicrob Agents Chemother; 1998 May; 42(5):1217-21. PubMed ID: 9593153 [TBL] [Abstract][Full Text] [Related]
12. Influence of acute renal failure on pharmacokinetics of phenolsulfonphthalein in rats: a comparative study in vivo and in the simultaneous perfusion system of liver and kidney. Yasuhara M; Katayama H; Fujiwara J; Okumura K; Hori R J Pharmacobiodyn; 1985 May; 8(5):377-84. PubMed ID: 4045695 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats. Park KJ; Yoon WH; Kim SH; Shin WG; Lee MG Biopharm Drug Dispos; 1998 Apr; 19(3):141-6. PubMed ID: 9569995 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic changes of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure. Kim HJ; Han KS; Chung YK; Chang MS; Lee MG Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):43-56. PubMed ID: 9920345 [TBL] [Abstract][Full Text] [Related]
15. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies. Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670 [TBL] [Abstract][Full Text] [Related]
16. Differential changes in functional activity of organic cation transporters in rats with uranyl nitrate-induced acute renal failure. Maeng HJ; Shim WS; Ahn SJ; Yu SS; Kim DD; Shim CK; Chung SJ Arch Pharm Res; 2012 Aug; 35(8):1441-8. PubMed ID: 22941487 [TBL] [Abstract][Full Text] [Related]
17. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate. Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. Terao N; Shen DD J Pharmacokinet Biopharm; 1984 Oct; 12(5):479-93. PubMed ID: 6520744 [TBL] [Abstract][Full Text] [Related]
19. Effect of acute renal failure on the disposition of cefoperazone. Katayama H; Yasuhara M; Hori R J Pharm Pharmacol; 1999 Mar; 51(3):361-6. PubMed ID: 10344639 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats. Lee AK; Kim EJ; Lee MG Res Commun Mol Pathol Pharmacol; 2003; 113-114():193-200. PubMed ID: 15686118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]